Checkpoint Therapeutics, Inc.
CKPTCIK 0001651407 · Every Form 4 filed by insiders at this issuer.
Filings
6
Latest Mar 22, 2024
Unique insiders
3
Showing
6 of 6
Page 1
Top insiders
Most active reporters at Checkpoint Therapeutics, Inc.
| Name | Roles | Filings |
|---|---|---|
| Fortress Biotech, Inc. | 10% Owner | 2 |
| GRAY WILLIAM GARRETT | Officer | 2 |
| Oliviero James F III | OfficerDirector | 2 |
All filings
6 Form 4 / 4-A filings, newest first
| Filed | Insider | Top transaction | Shares | Price | Value | |
|---|---|---|---|---|---|---|
| Mar 22, 2024 | Fortress Biotech, Inc. 10% Owner | A | 193,905 | $0.00 | $0 | |
| Mar 1, 2024 | GRAY WILLIAM GARRETT Chief Financial Officer | S | 2,035 | $2.07 | $4,212 | |
| Mar 1, 2024 | Oliviero James F III CEO, President and Director · Director | S | 5,894 | $2.06 | $12,142 | |
| Feb 2, 2024 | Oliviero James F III CEO, President and Director · Director | S | 11,900 | $2.01 | $23,919 | |
| Feb 2, 2024 | GRAY WILLIAM GARRETT Chief Financial Officer | S | 4,115 | $1.95 | $8,024 | |
| Jan 3, 2024 | Fortress Biotech, Inc. 10% Owner | A | 158,134 | $0.00 | $0 |
Showing 1–6 of 6
Page 1 of 1
Real-time Form 4 intelligence. Smarter insider tracking.